Michiel Verhofstad

Michiel Verhofstad is a Full Professor in the Department of Surgery at Erasmus MC, a leading academic medical center in the Netherlands. His work is centered on trauma and orthopedic surgery, with a focus on clinical outcomes, infection management, and fracture care. He actively contributes to national and international research collaborations, including the Dutch Hip Fracture Audit and the Stable-HIP group.

His research interests span a broad spectrum of trauma-related topics, including hip and pelvic fractures, rib fractures, fracture-related infections, and innovative treatments such as phage therapy. He frequently employs systematic reviews and retrospective cohort studies to evaluate treatment efficacy, patient outcomes, and healthcare utilization.

The recent publication trends highlight his leadership in infection control in orthopedic surgery, particularly in multidrug-resistant pathogens, and the development of novel experimental models to understand bone infection mechanisms. His work bridges clinical practice with translational research, aiming to improve patient care through evidence-based innovation.

Michiel Verhofstad has supervised 24 research projects or students, demonstrating his role in academic mentorship. He has no listed scientific awards in the provided text, but his extensive publication record and leadership in major collaborative studies reflect significant scholarly impact.

He is involved in key research networks and taskforces focused on hip fracture audits and trauma care optimization, contributing to healthcare policy and clinical guidelines through data-driven research.